Jane Street’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.92M Sell
10,469
-13,070
-56% -$2.41M ﹤0.01% 5178
2025
Q4
$4.14M Buy
23,539
+18,199
+341% +$2.97M ﹤0.01% 3523
2025
Q3
$748K Sell
5,340
-27,701
-84% -$3.74M ﹤0.01% 6944
2025
Q2
$4.15M Sell
33,041
-4,213
-11% -$525K ﹤0.01% 3265
2025
Q1
$5.1M Sell
37,254
-165,384
-82% -$23.6M ﹤0.01% 2913
2024
Q4
$31M Buy
202,638
+92,349
+84% +$15.6M 0.01% 952
2024
Q3
$21.4M Sell
110,289
-67,877
-38% -$14.2M ﹤0.01% 1193
2024
Q2
$41.3M Buy
178,166
+92,172
+107% +$20M 0.01% 798
2024
Q1
$18.5M Sell
85,994
-118,694
-58% -$27.8M ﹤0.01% 1244
2023
Q4
$53M Buy
204,688
+157,834
+337% +$38.8M 0.01% 645
2023
Q3
$12M Sell
46,854
-88,059
-65% -$23.6M ﹤0.01% 1579
2023
Q2
$38.4M Buy
134,913
+85,003
+170% +$25.3M 0.01% 731
2023
Q1
$13.9M Sell
49,910
-157,671
-76% -$43.6M 0.01% 1308
2022
Q4
$57.5M Sell
207,581
-96,959
-32% -$27.4M 0.03% 460
2022
Q3
$81.3M Buy
304,540
+114,830
+61% +$24.4M 0.04% 341
2022
Q2
$38.7M Buy
189,710
+6,227
+3% +$1.27M 0.02% 673
2022
Q1
$38.6M Buy
183,483
+22,992
+14% +$5M 0.01% 816
2021
Q4
$38.5M Buy
160,491
+66,321
+70% +$17.1M 0.01% 783
2021
Q3
$26.6M Buy
94,170
+11,484
+14% +$3.76M 0.01% 942
2021
Q2
$28.6M Sell
82,686
-40,009
-33% -$12.1M 0.01% 836
2021
Q1
$34.3M Sell
122,695
-122,116
-50% -$32.9M 0.02% 627
2020
Q4
$59.9M Buy
244,811
+129,054
+111% +$33.3M 0.03% 400
2020
Q3
$32.8M Sell
115,757
-43,590
-27% -$12.2M 0.02% 540
2020
Q2
$42.6M Buy
159,347
+127,915
+407% +$38.5M 0.03% 407
2020
Q1
$9.94M Sell
31,432
-17,389
-36% -$5.28M 0.01% 779
2019
Q4
$14.5M Sell
48,821
-20,660
-30% -$5.73M 0.02% 494
2019
Q3
$16.2M Buy
69,481
+2,602
+4% +$606K 0.03% 415
2019
Q2
$15.6M Sell
66,879
-48,473
-42% -$11.2M 0.03% 455
2019
Q1
$27.3M Buy
115,352
+101,280
+720% +$31.9M 0.04% 323
2018
Q4
$4.23M Sell
14,072
-33,485
-70% -$10.7M 0.01% 1048
2018
Q3
$16.8M Buy
47,557
+19,380
+69% +$6.67M 0.03% 383
2018
Q2
$8.18M Buy
28,177
+18,177
+182% +$5.11M 0.02% 725
2018
Q1
$2.74M Sell
10,000
-13,877
-58% -$4.31M 0.01% 1503
2017
Q4
$7.61M Sell
23,877
-445
-2% -$143K 0.02% 633
2017
Q3
$7.62M Sell
24,322
-14,359
-37% -$4.25M 0.02% 629
2017
Q2
$10.5M Buy
38,681
+904
+2% +$239K 0.04% 443
2017
Q1
$10.3M Buy
37,777
+26,990
+250% +$7.63M 0.05% 371
2016
Q4
$3.06M Sell
10,787
-23,735
-69% -$7.04M 0.01% 986
2016
Q3
$10.8M Sell
34,522
-16,213
-32% -$4.8M 0.05% 290
2016
Q2
$12.3M Buy
50,735
+27,089
+115% +$7.14M 0.06% 279
2016
Q1
$6.16M Buy
23,646
+4,370
+23% +$1.15M 0.03% 469
2015
Q4
$5.91M Sell
19,276
-17,583
-48% -$5.05M 0.04% 424
2015
Q3
$10.8M Buy
36,859
+25,861
+235% +$8.54M 0.07% 241
2015
Q2
$4.44M Buy
10,998
+2,569
+30% +$1.03M 0.03% 530
2015
Q1
$3.56M Buy
8,429
+2,930
+53% +$1.15M 0.03% 551
2014
Q4
$1.87M Buy
5,499
+4,628
+531% +$1.5M 0.01% 706
2014
Q3
$288K Sell
871
-699
-45% -$230K ﹤0.01% 1919
2014
Q2
$495K Buy
+1,570
New +$473K 0.01% 1415
2013
Q4
Sell
-5,080
Closed -$1.22M 2350
2013
Q3
$1.22M Sell
5,080
-45,208
-90% -$10.1M 0.01% 933
2013
Q2
$10.8M Buy
+50,288
New +$10.7M 0.19% 74

Other funds holding BIIB

Jane Street's BIIB Position: Q1 2026 in Review

Jane Street reduced its Biogen (BIIB) stake by 56% in Q1 2026, selling an estimated $2.41M and leaving 10,469 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #5178.

Jane Street first reported a position in BIIB in Q2 2013 and has held it in 50 quarters since. The position peaked at $81.3M in Q3 2022. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Jane Street held 10,469 shares of Biogen worth $1.92M as of Q1 2026.
  • Jane Street sold 13,070 Biogen shares in Q1 2026, an estimated $2.41M.
  • Biogen made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5178 holding.
  • Jane Street first reported a position in Biogen in Q2 2013 and has held it in 50 quarters since.
  • Jane Street's Biogen position peaked at $81.3M in Q3 2022.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.